Search Result "Dacomitinib"

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 9 Year: 2014 Page: 775-793
Author(s): Deepa Subramaniam,Aiwu R. He,Jimmy Hwang,John Deeken,Michael Pishvaian,Marion L. Hartley,John L. Marshall

HER2 Targeted Monoclonal Antibodies and Tyrosine Kinase Inhibitors

Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Neil A. O`Brien,Alexandra Canonici,Karen Howe,Martina S.J. McDermott,Denis M. Collins,Brigid C. Browne,John Crown,Norma O`Donovan
Doi: 10.2174/978160859225114040007

Review Article

Irreversible Kinase Inhibitors Targeting Cysteine Residues and their Applications in Cancer Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 17 Year: 2020 Page: 1732-1753
Author(s): Debasis Das,Jian Hong

Research Article

In Silico Screening of Some Anti-Cancer Drugs Against the Main Proteaseof COVID-19 Using Molecular Docking

Journal: Letters in Organic Chemistry
Volume: 20 Issue: 1 Year: 2023 Page: 77-90
Author(s):

General Research Article

Structure-based Virtual Screening, Molecular Docking, MolecularDynamics Simulation, and Metabolic Reactivity Studies ofQuinazoline Derivatives for their Anti-EGFR Activity AgainstTumor Angiogenesis

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 5 Year: 2024 Page: 595-619
Author(s): Altaf Ahmad Shah,Manoj Kumar Yadav,Mohammad Amjad Kamal

Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Battle against Drug Resistant Lung Cancer

Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Kenneth K.W. To,Wing-Sum Tong
Doi: 10.2174/9789811405150119050008

Review Article

An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs(2018-2021)

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 24 Issue: 8 Year: 2024 Page: 590-626
Author(s):

Epidermal Growth Factor Receptor Targeting in Non-Small Cell Lung Cancer: Revisiting Different Strategies Against the Same Target

Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1273-1283
Author(s): Eduardo Castanon,Patricia Martin,Christian Rolfo,Juan P. Fusco,Lucia Ceniceros,Jairo Legaspi,Marta Santisteban,Ignacio Gil-Bazo

The Treatment of Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 1 Year: 2013
Author(s): Vera Hirsh
Doi: 10.2174/9781608057986113010006

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 818-832
Author(s): Elena Galvani,Roberta Alfieri,Elisa Giovannetti,Andrea Cavazzoni,Silvia La Monica,Maricla Galetti,Claudia Fumarola,Mara Bonelli,Marco Mor,Marcello Tiseo,Godefridus J. Peters,Pier Giorgio Petronini,Andrea Ardizzoni

Previous   Next

Go To   Results 1 - 1 of 67

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy